// App-Quantinova.ai

AEP180 : Baseline characteristics from the observational paradighm registry of patients with chronic hypoparathyroidism

Researchers

Presenter

  • Bart L Clarke

Principal Investigators

  • Lars Rejnmark

  • Steven Ing

  • Maria Luisa Brandi

  • Sigridur Bjrnsdottir

  • Stefanie Hahner

  • Lorenz C Hofbauer

  • Pascal Houillier

  • Aliya A Khan

  • Michael A Levine

  • Michael Mannstadt

  • Dolores M Shoback

  • Tamara J Vokes

  • Pinggao Zhang

  • Claudio Marelli

  • John Germak

  • Neil Gittoes

Medical Centers

  • Mayo Clinic Rochester, Division of Endocrinology, Diabetes, Metabolism, & Nutrition, Minnesota, United States

  • Aarhus University and Aarhus University Hospital, Endocrinology and Internal Medicine, Aarhus, Denmark

  • Ohio State University Wexner Medical Center, Endocrinology, Diabetes and Metabolism, Ohio, United States

  • University Hospital of Careggi, Endocrinology and Metabolic Diseases, Florence, Italy

  • Karolinska Institutet, Department of Molecular Medicine and Surgery (MMK), Stockholm, Sweden

  • University of Würzburg, Department of Medicine I, Endocrinology and Diabetology, Würzburg, Germany

  • Technische Universität Dresden, Endocrinology, Diabetes, and Osteology, Dresden, Germany

  • Georges Pompidou European Hospital and Paris University, Metabolism and Physiology, Paris, France

  • McMaster University, Department of Medicine, Divisions of Endocrinology and Metabolism and Geriatric Medicine, Ontario, Canada

  • Children’s Hospital of Philadelphia, Endocrinology and Diabetes, Pennsylvania, United States

  • Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States

  • San Francisco Veteran Affairs Medical Center

  • University of California, San Francisco, Endocrine Research Unit − 111N, California, United States

  • University of California, Davis, Davis, California, United States

  • University of Chicago, Section of Endocrinology, Illinois, United States

  • Shire Human Genetic Therapies, Inc., a Takeda company, US Medical Affairs, Massachusetts, United States

  • Shire International GmbH, Takeda company, Global Medical Affairs, Glattpark-Opfikon (Zurich), Switzerland

  • Shire Human Genetic Therapies, Inc., a Takeda company, US Medical Affairs, Massachusetts, United States

  • University of Birmingham, Centre for Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham, United Kingdom

Locations

  • United States

  • Denmark

  • Italy

  • Sweden

  • Germany

  • France

  • Canada

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hypoparathyroidism

  • Thyroid Cancer

  • Anxiety

  • Solid malignancies

Biomarkers

  • Body mass index

Drug/Treatment

  • rhPTH

  • Calcium Acetate tablet

  • Levothyroxine

  • Alfacalcidol

  • Liothyronine sodium

  • Recombinant Human Parathyroid Hormone (1-84)

  • Ergocalciferol

  • Calcitriol

  • MK8970

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved